发布求助
文献互助 智能选刊 最新文献

Australian Prescriber最新文献

筛选
英文 中文
New Drug: Elasomeran+davesomeran for prevention of COVID-19 预防COVID-19的新药:Elasomeran+davesomeran
Australian Prescriber Pub Date : 2023-10-24 DOI: 10.18773/austprescr.2023.018
{"title":"New Drug: Elasomeran+davesomeran for prevention of COVID-19","authors":"","doi":"10.18773/austprescr.2023.018","DOIUrl":"https://doi.org/10.18773/austprescr.2023.018","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"61 11","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135220371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 vaccines in 2023 2023年的COVID-19疫苗
Australian Prescriber Pub Date : 2023-10-24 DOI: 10.18773/austprescr.2023.020
Ketaki Sharma, Jean Li-Kim-Moy
{"title":"COVID-19 vaccines in 2023","authors":"Ketaki Sharma, Jean Li-Kim-Moy","doi":"10.18773/austprescr.2023.020","DOIUrl":"https://doi.org/10.18773/austprescr.2023.020","url":null,"abstract":"SUMMARY Most Australian adults now have hybrid immunity to the SARS-CoV-2 virus, referring to a combination of protection from previous vaccine doses and past infection. Protection from both vaccination and past infection wanes over time. Booster doses are recommended to ensure that those who are at increased risk of severe COVID-19 remain protected. The optimal timing of future booster doses to maintain adequate protection against severe illness is not yet known. Older age remains the most important risk factor for severe COVID-19, including in the current Omicron variant era. The original COVID-19 vaccines are monovalent vaccines based on the ancestral strain of the SARS-CoV-2 virus. Bivalent vaccines have been developed based on earlier Omicron subvariants (BA.1 or BA.4-5) and the ancestral strain. These provide enhanced protection against severe illness from Omicron compared with the original monovalent vaccines. Updated monovalent vaccines based on a more recent Omicron subvariant (XBB.1.5) have been developed. COVID-19 vaccines have an excellent safety record, and serious adverse events are extremely rare.","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"39 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135220372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Latest News: Update on changing Australian medicine names 最新消息:更改澳大利亚药品名称的最新情况
Australian Prescriber Pub Date : 2023-10-24 DOI: 10.18773/austprescr.2023.016
{"title":"Latest News: Update on changing Australian medicine names","authors":"","doi":"10.18773/austprescr.2023.016","DOIUrl":"https://doi.org/10.18773/austprescr.2023.016","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135220376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Drug: Finerenone for chronic kidney disease associated with type 2 diabetes with albuminuria 新药:芬纳酮治疗2型糖尿病伴蛋白尿的慢性肾病
Australian Prescriber Pub Date : 2023-10-24 DOI: 10.18773/austprescr.2023.017
{"title":"New Drug: Finerenone for chronic kidney disease associated with type 2 diabetes with albuminuria","authors":"","doi":"10.18773/austprescr.2023.017","DOIUrl":"https://doi.org/10.18773/austprescr.2023.017","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"7 5","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135220373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital health and prescribing: declare the past, diagnose the present, foretell the future. 数字医疗与处方：宣告过去，诊断现在，预言未来。
IF 2.7
Australian Prescriber Pub Date : 2023-10-01 DOI: 10.18773/austprescr.2023.015
Jodie A Austin, Michael A Barras, Clair M Sullivan
{"title":"Digital health and prescribing: declare the past, diagnose the present, foretell the future.","authors":"Jodie A Austin, Michael A Barras, Clair M Sullivan","doi":"10.18773/austprescr.2023.015","DOIUrl":"10.18773/austprescr.2023.015","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"46 3","pages":"46-47"},"PeriodicalIF":2.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665093/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138489213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prescribing and peritoneal dialysis. 处方和腹膜透析
IF 2.7
Australian Prescriber Pub Date : 2023-06-01 DOI: 10.18773/austprescr.2023.001
Frank Reimann, Melinda Tomlins
{"title":"Prescribing and peritoneal dialysis.","authors":"Frank Reimann, Melinda Tomlins","doi":"10.18773/austprescr.2023.001","DOIUrl":"10.18773/austprescr.2023.001","url":null,"abstract":"<p><p>Peritoneal dialysis is a home-based therapy for patients with end-stage kidney disease. It is less efficient in removing solutes and fluid than haemodialysis but offers more flexibility and independence. Peritoneal transport characteristics affect the dialysis prescription. The timing of drug administration is independent of the dialysis process except for the administration of intraperitoneal antibiotics. Dose reductions should follow current recommendations for patients with kidney disease. Fluid overload is common in patients undergoing peritoneal dialysis. Residual kidney function can ameliorate this problem and needs to be preserved. Dialysis solutions with high glucose concentrations contribute to adverse metabolic effects. Peritoneal dialysis-related catheter complications and infections may require patients to transition to haemodialysis. Antifungal prophylaxis needs to be co-administered for the duration of antibiotic courses for any indication to reduce the risk of fungal peritonitis. Close communication with the patient's supervising dialysis unit is required.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"1 1","pages":"5-8"},"PeriodicalIF":2.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664089/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41407428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Australian Prescriber: a new chapter. 澳大利亚处方集：新篇章。
IF 2.7
Australian Prescriber Pub Date : 2023-06-01 DOI: 10.18773/austprescr.2023.008
Leigh-Anne Claase
{"title":"<i>Australian Prescriber</i>: a new chapter.","authors":"Leigh-Anne Claase","doi":"10.18773/austprescr.2023.008","DOIUrl":"10.18773/austprescr.2023.008","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"46 1","pages":"2"},"PeriodicalIF":2.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664090/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138489214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood pressure elevations in hospital. 医院血压升高。
IF 2.7
Australian Prescriber Pub Date : 2022-12-01 DOI: 10.18773/austprescr.2022.068
Arduino A Mangoni, Elzbieta A Jarmuzewska, Genevieve M Gabb, Patrick Russell
{"title":"Blood pressure elevations in hospital.","authors":"Arduino A Mangoni,&nbsp;Elzbieta A Jarmuzewska,&nbsp;Genevieve M Gabb,&nbsp;Patrick Russell","doi":"10.18773/austprescr.2022.068","DOIUrl":"https://doi.org/10.18773/austprescr.2022.068","url":null,"abstract":"<p><p>Long-term hypertension control in the community significantly reduces cardiovascular risk. However, the benefit of controlling acute elevations of blood pressure in hospitalised patients is unclear. In-hospital elevations of blood pressure are relatively common and might not reflect poorly controlled blood pressure before admission. The measurement of blood pressure in hospital patients significantly differs from the best practice recommended for primary care and outpatients. Recent observational studies suggest that the pharmacological treatment of acute, asymptomatic, in-hospital elevations of blood pressure may have no benefit. However, it may increase the risk of in-hospital and post-discharge complications. Pending the development of robust inpatient measurement protocols, acute blood pressure elevations in hospitalised patients should not routinely require antihypertensive treatment in the absence of symptoms or acute end-organ damage. Rather, such elevations should facilitate follow-up of blood pressure and other cardiovascular risk factors after discharge.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"45 6","pages":"205-207"},"PeriodicalIF":2.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cb/e7/austprescr-45-205.PMC9722348.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10740659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Erratum: Bariatric surgery and medicines [Correction]. 更正:减肥手术和药物[更正]。
IF 2.7
Australian Prescriber Pub Date : 2022-12-01 DOI: 10.18773/austprescr.2022.074
{"title":"Erratum: Bariatric surgery and medicines [Correction].","authors":"","doi":"10.18773/austprescr.2022.074","DOIUrl":"https://doi.org/10.18773/austprescr.2022.074","url":null,"abstract":"<p><p>[This corrects the article on p. 162 in vol. 45, PMID: 36382169.].</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"45 6","pages":"219"},"PeriodicalIF":2.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/67/65/austprescr-45-219.PMC9722356.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10370818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wither Australian Prescriber? 枯萎澳大利亚处方?
IF 2.7
Australian Prescriber Pub Date : 2022-12-01 DOI: 10.18773/austprescr.2022.076
John Dowden
{"title":"Wither <i>Australian Prescriber</i>?","authors":"John Dowden","doi":"10.18773/austprescr.2022.076","DOIUrl":"https://doi.org/10.18773/austprescr.2022.076","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"45 6","pages":"210"},"PeriodicalIF":2.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/84/2e/austprescr-45-210.PMC9722344.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10370817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信